IP Library Granted Patent US 12,203,075
Granted Patent B2
US 12,203,075 · App. 16/700,009 · Granted Jan 21, 2025

Polyunsaturated fatty acid synthase nucleic acid molecules and polypeptides, compositions, and methods of making and uses thereof

Inventors: Kirk E. Apt (Ellicott City, MD); Leslie Richter (Broomfield, CO); David Simpson (Boulder, CO); Ross Zirkle (Mt. Airy, MD)
Assignee: DSM IP Assets B.V.
C12N15/52C12N9/0006C12N9/001C12N9/1029C12N9/88C12N15/8247C12P7/6432C12P7/6434C12P7/6472C12Y101/01C12Y203/01039C12Y203/01041C12Y402/01059A61K38/00C12Y103/01C12Y402/01Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,203,075
App. No.
16/700,009
Granted
Jan 21, 2025
Kind
B2
Abstract

The present invention is directed to isolated nucleic acid molecules and polypeptides of thraustochytrid polyunsaturated fatty acid (PUFA) synthases involved in the production of PUFAs, including PUFAs enriched in docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or a combination thereof. The present invention is directed to vectors and host cells comprising the nucleic acid molecules, polypeptides encoded by the nucleic acid molecules, compositions comprising the nucleic acid molecules or polypeptides, and methods of making and uses thereof.

Claims (11)

1. A recombinant nucleic acid molecule comprising a polynucleotide sequence at least 90% identical to SEQ ID NO:1 and a transcription control sequence, wherein the polynucleotide sequence encodes a polypeptide comprising beta-keto acyl-ACP synthase (KS) activity, malonyl-CoA: ACP acyltransferase (MAT) activity, acyl carrier protein (ACP) activity, ketoreductase (KR) activity, and beta-hydroxyacyl-ACP dehydrase (DH) activity, wherein said polynucleotide sequence is heterologous to said transcription control sequence.

2. The recombinant nucleic acid molecule of claim 1 , wherein the polynucleotide sequence is at least 95% identical to SEQ ID NO:1.

3. The recombinant nucleic acid molecule of claim 1 , wherein the nucleic acid molecule comprises the polynucleotide sequence sequences of SEQ ID NO:1.

4. A recombinant nucleic acid molecule comprising a polynucleotide sequence encoding a polypeptide and a transcription control sequence, wherein the polypeptide comprises an amino acid sequence at least 90% identical to SEQ ID NO:2, wherein the polypeptide comprises beta-keto acyl-ACP synthase (KS) activity, malonyl-CoA: ACP acyltransferase (MAT) activity, acyl carrier protein (ACP) activity, ketoreductase (KR) activity, and beta-hydroxyacyl-ACP dehydrase (DH) activity, wherein said polynucleotide sequence is heterologous to said transcription control sequence.

5. The recombinant nucleic acid molecule of claim 4 , wherein the amino acid sequence is at least 95% identical to SEQ ID NO:2.

6. The recombinant nucleic acid molecule of claim 4 , wherein the polypeptide comprises the amino acid sequence of SEQ ID NO:2.

7. A host cell that expresses the nucleic acid molecule of claim 1 or claim 4 , wherein said nucleic acid molecule is heterologous to the host cell, and wherein said host cell is not a human cell.

8. The host cell of claim 7 , wherein the host cell is selected from the group consisting of a plant cell, a microbial cell, and an isolated animal cell.

9. A method to produce at least one polyunsaturated fatty acid (PUFA), comprising: expressing a PUFA synthase gene in a host cell under conditions effective to produce PUFA, wherein the PUFA synthase gene comprises a nucleic acid molecule comprising a polynucleotide sequence at least 90% identical to SEQ ID NO: 1 or a polynucleotide sequence encoding a polypeptide which comprises an amino acid sequence at least 90% identical to SEQ ID NO:2, wherein said nucleic acid molecule is heterologous to the host cell, wherein said polynucleotide sequence encodes a PUFA synthase polypeptide comprising beta-keto acyl-ACP synthase (KS) activity, malonyl-CoA: ACP acyltransferase (MAT) activity, acyl carrier protein (ACP) activity, ketoreductase (KR) activity, and beta-hydroxyacyl-ACP dehydrase (DH) activity, and wherein at least one PUFA is produced.

10. A method to produce lipids enriched for docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or a combination thereof as compared to a host cell not expressing a polyunsaturated fatty acid (PUFA) synthase gene as claimed, comprising: expressing a PUFA synthase gene in a host cell under conditions effective to produce lipids, wherein the PUFA synthase gene comprises a nucleic acid molecule comprising a polynucleotide sequence at least 90% identical to SEQ ID NO:1 or a polynucleotide sequence encoding a polypeptide which comprises an amino acid sequence at least 90% identical to SEQ ID NO: 2, wherein said nucleic acid molecule is heterologous to the host cell, wherein said polynucleotide sequence encodes a PUFA synthase polypeptide comprising beta-hydroxyacyl-ACP dehydrase (DH) activity and enoyl-ACP reductase (ER) activity, beta-keto acyl-ACP synthase (KS) activity, malonyl-CoA: ACP acyltransferase (MAT) activity, acyl carrier protein (ACP) activity, ketoreductase (KR) activity, and beta-hydroxyacyl-ACP dehydrase (DH) activity, and wherein lipids enriched with DHA, EPA, or a combination thereof are produced.

11. A method of increasing production of docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or a combination thereof in an organism having polyunsaturated fatty acid (PUFA) synthase activity, comprising: expressing the recombinant nucleic acid molecule of claim 1 or claim 4 in the organism under conditions effective to produce DHA, EPA, or a combination thereof, wherein the PUFA synthase activity replaces an inactive or deleted activity, introduces a new activity, or enhances an existing activity in the organism, and wherein production of DHA, EPA, or a combination thereof in the organism is increased.

Assignments (1)
CHANGE OF ASSIGNEE ADDRESS Recorded Sep 12, 2025
From: DSM IP ASSETS B.V.
To: DSM IP ASSETS B.V.
Reel/Frame 072874/0222 →
Continuity (6)
Division 15371410 · Dec 7, 2016
Division 14566458 · Dec 10, 2014
Division 12727851 · Mar 19, 2010
Provisional Application 61296460 · Jan 19, 2010
Provisional Application 61161742 · Mar 19, 2009
Related Publication 20200199598A1 · Jun 25, 2020
References Cited (61)
US 4721626A · Rule · 1988 [cited by applicant]
US 5601860A · Lien et al. · 1997 [cited by applicant]
US 5952544A · Browse et al. · 1999 [cited by applicant]
US 5981781A · Knowlton · 1999 [cited by applicant]
US 6036992A · Borror et al. · 2000 [cited by applicant]
US 6051754A · Knutzon · 2000 [cited by applicant]
US 6160007A · DeMichele · 2000 [cited by applicant]
US 6372965B1 · Lightner et al. · 2002 [cited by applicant]
US 6432684B1 · Mukerji et al. · 2002 [cited by applicant]
US 6566583B1 · Facciotti et al. · 2003 [cited by applicant]
US 7211418B2 · Metz et al. · 2007 [cited by applicant]
US 7217856B2 · Weaver · 2007 [cited by examiner]
US 7247461B2 · Metz et al. · 2007 [cited by applicant]
US 7256023B2 · Metz et al. · 2007 [cited by applicant]
US 7700320B2 · Metz et al. · 2010 [cited by applicant]
US 8003772B2 · Weaver et al. · 2011 [cited by applicant]
US 8426686B2 · Metz et al. · 2013 [cited by applicant]
US 8829274B2 · Facciotti et al. · 2014 [cited by applicant]
US 9994828B2 · Walsh et al. · 2018 [cited by applicant]
US 20020194641A1 · Metz et al. · 2002 [cited by applicant]
US 20030101486A1 · Facciotti et al. · 2003 [cited by applicant]
US 20040235127A1 · Metz et al. · 2004 [cited by applicant]
US 20050014231A1 · Mukerji et al. · 2005 [cited by applicant]
US 20050100995A1 · Weaver et al. · 2005 [cited by applicant]
US 20050255440A1 · Downing · 2005 [cited by applicant]
US 20050273883A1 · Metz et al. · 2005 [cited by applicant]
US 20050273884A1 · Metz et al. · 2005 [cited by applicant]
US 20070244192A1 · Metz et al. · 2007 [cited by applicant]
US 20070266455A1 · Weaver et al. · 2007 [cited by applicant]
US 20080038794A1 · Metz et al. · 2008 [cited by applicant]
US 20080044871A1 · Metz et al. · 2008 [cited by applicant]
US 20080144473A1 · Morimoto et al. · 2008 [cited by applicant]
US 20180282711A1 · Walsh et al. · 2018 [cited by applicant]
AU 2007226510 · 2007 [cited by applicant]
AU 2013251201 · 2013 [cited by applicant]
CA 2646317 · 2007 [cited by applicant]
CA 2755639 · 2010 [cited by applicant]
CN 1535312 · 2004 [cited by applicant]
CN 104073505 · 2014 [cited by applicant]
EP 0913473 · 1999 [cited by applicant]
WO WO1998044917 · 1998 [cited by applicant]
WO WO2002094861 · 2002 [cited by applicant]
WO WO2004087879 · 2004 [cited by applicant]
WO WO2005097982 · 2005 [cited by applicant]
WO WO2006037947 · 2006 [cited by applicant]
WO WO2006125231 · 2006 [cited by applicant]
WO WO2006135866 · 2006 [cited by applicant]
WO WO2007106903 · 2007 [cited by applicant]
WO WO2007106908 · 2007 [cited by applicant]
WO WO2010108114 · 2010 [cited by applicant]
Hauvermale et al., Fatty acid production in [cited by examiner]
Tonan et al, XP002635611 (2005). [cited by applicant]
Witkowski et al, “ [cited by applicant]
Tonan et al, “ [cited by applicant]
Shockey et al, “ [cited by applicant]
Seffernick et al, [cited by applicant]
Old, R.W., “Principles of gene manipulation: an introduction to genetic engineering”, Studies in Microbiology, v. 2, 3rd ed., 1985. [cited by applicant]
Kendrick et al, “ [cited by applicant]
Ivanova et al, “ [cited by applicant]
Branden et al, “ [cited by applicant]
Skerratt et al, “ [cited by applicant]